|Mr. Marc Lustig M.B.A., M.Sc.||Exec. Chairman||452.97k||N/A||1974|
|Mr. Oren Shuster||CEO & Director||413.87k||N/A||N/A|
|Mr. Shai Shemesh||Chief Financial Officer||249.49k||N/A||N/A|
|Mr. Richard Balla||CEO & Director of German Operations Adjupharm GmbH||315.23k||N/A||N/A|
|Advocate Yael Harrosh||Chief Legal & Operations Officer||N/A||N/A||N/A|
|Mr. Michael Ruscetta||Co-Head of North America & CEO of Trichome Financial Corp.||N/A||N/A||1970|
|Mr. Howard Steinberg C.F.A.||Co-Head of North America & CEO of TJAC||N/A||N/A||1966|
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
IM Cannabis Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.